Texas 89th Legislature, Regular Session Status: Introduced

HB 3717 — Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.

Last action — Laid on the table subject to call

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 89th Legislature, Regular Session. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Summary

Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.

Bill Text

We don't have the full text on file for this bill yet.

Read HB 3717 on the official Texas source →

Action History

  1. Laid on the table subject to call

  2. Companion considered in lieu of

  3. Postponed

  4. Laid out as postponed business

  5. Postponed

  6. Laid out as postponed business

  7. Postponed

  8. Laid out as postponed business

  9. Postponed

  10. Read 2nd time

  11. Placed on General State Calendar

  12. Considered in Calendars

  13. Committee report sent to Calendars

  14. Committee report distributed

  15. Comte report filed with Committee Coordinator

  16. Reported favorably w/o amendment(s)

  17. Considered in public hearing

  18. Left pending in committee

  19. Testimony taken/registration(s) recorded in committee

  20. Considered in public hearing

  21. Scheduled for public hearing on . . .

  22. Referred to Public Health

  23. Read first time

  24. Filed

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 33 co-sponsors · 150 not signed on

Sponsors (1)

Co-sponsors (33)

Not signed on (150)

150 members have not signed on to this bill.

Show all 150 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare labor health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 3717 do?
Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
Who sponsors HB 3717?
HB 3717 is sponsored by Josey Garcia, Cole Hefner, Marc LaHood, Cody Harris, Jeff Leach, Dade Phelan, Angelia Orr, Gary VanDeaver, Daniel Alders, Jeff Barry, Keith Bell, Brad Buckley, Briscoe Cain, Aicha Davis, Erin Gámez, Stan Gerdes, Suleman Lalani, Janie Lopez, John Lujan, Don McLaughlin, Will Metcalf, Penny Morales Shaw, Eddie Morales, Mike Olcott, Katrina Pierson, Richard Peña Raymond, Alan Schoolcraft, Joanne Shofner, Valoree Swanson, Tony Tinderholt, Cody Vasut, Denise Villalobos, Erin Zwiener, and Leo Wilson.
What is the current status of HB 3717?
This bill died with 89th Legislature, Regular Session. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 3717?
Track HB 3717 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 3717

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 3717

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →